Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

INGN stock hub

Inogen, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

INGNis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
191.8M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
INGN
In the news

Latest news · INGN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-13.1
P25 -105.6P50 -46.5P75 -3.1
ROIC-33.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All INGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
USD
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001294133
Company name
Inogen, Inc.
Country
United States
Country code
US
Cusip
45780L104
Employees
753
Employees Change
-13%
Employees Change Percent
-1.7
Enterprise value
$98.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2014-02-14
Isin
US45780L1044
Last refreshed
2026-05-10
Market cap
$191.8M
Market cap category
Micro-Cap
Price
$7.02
Price currency
USD
Rev Per Employee
466,795.48x
Sector
Healthcare
Sic
3842
Symbol
INGN
Website
https://www.provider.inogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-12.98%
EV Sales Forward
0.25x
EV/Sales
0.28x
FCF yield
-5.34%
P/B ratio
1.05x
P/S ratio
0.55x
PS Forward
0.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-8.56%
EBITDA Margin
-2.77%
Gross margin
44.31%
Gross Profit
$155.8M
Gross Profit Growth
-0.63%
Gross Profit Growth Q
4.1%
Gross Profit Growth3 Y
1.43%
Gross Profit Growth5 Y
2.2%
Net Income
$-24.9M
Net Income Growth Years
2%
Pretax Margin
-7.28%
Profit Margin
-7.08%
Profit Per Employee
$-33,064
ROA
-6.33
Roa5y
-6.35
ROCE
-13.41
ROE
-13.07
Roe5y
-19.81
ROIC
-33.49
Roic5y
-32.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-17.54%
Cagr1y
-2.09%
Cagr3y
-18.58%
Cagr5y
-36.24%
EPS Growth Years
2
Revenue Growth
3.39x
Revenue Growth Q
3.44x
Revenue Growth Quarters
9x
Revenue Growth Years
2x
Revenue Growth3 Y
-1.61x
Revenue Growth5 Y
2.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$1.18
Assets
$285.9M
Cash
$110.2M
Current Assets
$190.7M
Current Liabilities
$61.4M
Debt
$16.9M
Debt Equity
$0.09
Equity
$182.9M
Liabilities
$103M
Long Term Assets
$95.3M
Long Term Liabilities
$41.6M
Net Cash
$93.2M
Net Cash By Market Cap
$48.61
Net Cash Growth
-6.47%
Net Debt Equity
$-0.51
Tangible Book Value
$143.5M
Tangible Book Value Per Share
$5.25
WACC
12.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.1
Inventory Turnover
7.64
Net Working Capital
$22.5M
Quick ratio
2.47
Working Capital
$129.2M
Working Capital Turnover
$2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-12.64%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

41
MetricValue
10Y total return
-85.46%
1Y total return
-2.09%
200-day SMA
7.04
3Y total return
-46.04%
50-day SMA
6.55
50-day SMA vs 200-day SMA
50under200
5Y total return
-89.46%
All Time High
287.8
All Time High Change
-97.56%
All Time High Date
2018-09-13
All Time Low
4.13
All Time Low Change
69.98%
All Time Low Date
2023-10-27
ATR
0.36
Beta
1.65
Beta1y
1.03
Beta2y
1.15
Ch YTD
4.46
High
7.43
High52
9.13
High52 Date
2025-10-22
High52ch
-23.11%
Low
6.6
Low52
5.34
Low52 Date
2026-02-25
Low52ch
31.46%
Ma50ch
7.18%
Premarket Change Percent
3.34
Premarket Price
$7.43
Premarket Volume
3,967
Price vs 200-day SMA
-0.31%
RSI
54.98
RSI Monthly
43.04
RSI Weekly
54.92
Sharpe ratio
0.11x
Sortino ratio
0.3
Total Return
-12.64%
Tr YTD
4.46
Tr1m
3.24%
Tr1w
0.57%
Tr3m
24.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

9
MetricValue
Analyst Count
3
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.22
Earnings Revenue Estimate
82,360,000x
Earnings Revenue Estimate Growth
0.1x
Operating Income
$-30.1M
Operating margin
-8.56
Price target
$12.67
Price Target Change
$80.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
24,103,933%
Float Percent
88.21%
Shares Insiders
2.17%
Shares Institutions
72.41%
Shares Out
27,324,616
Shares Qo Q
0.54%
Shares Yo Y
12.64%
Short Float
4.14%
Short Ratio
4.04
Short Shares
3.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
$-18.1M
Average Volume
333,826.05x
Bv Per Share
6.69
CAPEX
$-9.1M
Ch10y
-85.46
Ch1m
3.24
Ch1w
0.57
Ch1y
-2.09
Ch3m
24.03
Ch3y
-46.04
Ch5y
-89.46
Ch6m
0.43
Change
-2.36%
Change From Open
-2.09
Close
7.19
Days Gap
-0.28
Depreciation Amortization
20,374,000
Dollar Volume
5,755,382.1
Earnings Date
2026-05-07
Earnings Time
amc
EBIT
$-30.1M
EBITDA
$-9.7M
EPS
$-0.92
F Score
3
FCF
$-10.2M
FCF EV Yield
-10.38x
FCF Per Share
$-0.37
Financing CF
-1,892,000
Fiscal Year End
December
Founded
2,001
Goodwill
10,483,000
Income Tax
$-709,000
Investing CF
-26,146,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-27
Ma150
6.82
Ma150ch
2.89%
Ma20
6.93
Ma20ch
1.36%
Net CF
-28,131,000
Next Earnings Date
2026-08-06
Open
7.17
Optionable
Yes
Position In Range
50.6
Ppne
49,414,000
Pre Close
7.19
Price Date
2026-05-08
Ptbv Ratio
1.34
Relative Volume
2.46x
Revenue
351,497,000x
SBC By Revenue
2.22x
Share Based Comp
7,817,000
Tax By Revenue
-0.2x
Tr6m
0.43%
Us State
Massachusetts
Volume
819,855
Z Score
1.62
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does INGN pay a dividend?

Capital-return profile for this ticker.

Performance

INGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-2.1%
S&P 500 1Y: n/a
3Y total return
-46.0%
S&P 500 3Y: n/a
5Y total return
-89.5%
S&P 500 5Y: n/a
10Y total return
-85.5%
S&P 500 10Y: n/a
Ownership

Who owns INGN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+72.4%
Float: +88.2% of shares outstanding
Insider ownership
+2.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+4.1%
4.0 days to cover
Y/Y dilution
+12.6%
Negative means the company is buying back shares.
Technical

INGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.0
Neutral momentum band
Price vs 200-day MA
-0.3%
50/200-day relationship not available
Beta (5Y)
1.65
More volatile than the market
Sharpe ratio
0.11
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About INGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INGN stock rating?

Inogen, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INGN analysis?

The full report lives at /stocks/INGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INGN?

The latest report frames INGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.